194 related articles for article (PubMed ID: 22699093)
1. Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2012 Nov; 126(1-2):216-23. PubMed ID: 22699093
[TBL] [Abstract][Full Text] [Related]
2. Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2012 Apr; 122(1-2):61-9. PubMed ID: 21975195
[TBL] [Abstract][Full Text] [Related]
3. Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2014 Oct; 143():141-8. PubMed ID: 25124305
[TBL] [Abstract][Full Text] [Related]
4. Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.
Lile JA; Wesley MJ; Kelly TH; Hays LR
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):215-24. PubMed ID: 26313650
[TBL] [Abstract][Full Text] [Related]
5. Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
Lile JA; Kelly TH; Pinsky DJ; Hays LR
Psychopharmacology (Berl); 2009 Apr; 203(2):241-50. PubMed ID: 19018520
[TBL] [Abstract][Full Text] [Related]
6. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
[TBL] [Abstract][Full Text] [Related]
7. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the subjective effects of oral Δ
Fogel JS; Kelly TH; Westgate PM; Lile JA
Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders.
Gray KM; Hart CL; Christie DK; Upadhyaya HP
Pharmacol Biochem Behav; 2008 Nov; 91(1):67-70. PubMed ID: 18627775
[TBL] [Abstract][Full Text] [Related]
10. Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination.
Wiley JL; Martin BR
Pharmacol Biochem Behav; 1999 Nov; 64(3):519-22. PubMed ID: 10548265
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
13. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
15. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
Stewart JL; McMahon LR
J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.
Winsauer PJ; Filipeanu CM; Bailey EM; Hulst JL; Sutton JL
Pharmacol Biochem Behav; 2012 Sep; 102(3):442-9. PubMed ID: 22705493
[TBL] [Abstract][Full Text] [Related]
17. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221
[TBL] [Abstract][Full Text] [Related]
18. Cannabis: discrimination of "internal bliss"?
Wiley JL
Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
[TBL] [Abstract][Full Text] [Related]
19. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA
Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
